WEEKLY NEWSLETTER

Free Health for Women Email Newsletter
Stay fit, feel younger, and get special offers and insider health news—from beauty to breast cancer—just for women.
Condition Center

Ovarian Cancer

Ovarian cancer is a type of cancer that starts in the ovaries. It most often occurs in women over 50. Ovarian cancer may cause no symptoms at all, or cause symptoms, such as bloating, abdominal pain, and trouble eating, that can be mistaken for other conditions. Although it’s difficult to catch ovarian cancer early—about 20% of ovarian cancers are detected before they spread outside the ovary—there are treatments that can help.

Ovarian Cancer News

  • ‘Generally Reassuring’ Findings on Fertility Drugs, Women’s Cancers

    WEDNESDAY, July 2, 2014 (HealthDay News) — Use of fertility drugs doesn’t appear to increase a woman’s long-term risk of breast, ovarian and uterine cancers, new research indicates. The findings are “generally reassuring,” said study co-author Dr. Humberto Scoccia, of the University of Illinois at Chicago. Still, he urged that women who use fertility drugs be [...]

  • ‘Generally Reassuring’ Findings on Fertility Drugs, Women’s Cancers

    WEDNESDAY, July 2, 2014 (HealthDay News) — Use of fertility drugs doesn’t appear to increase a woman’s long-term risk of breast, ovarian and uterine cancers, new research indicates. The findings are “generally reassuring,” said study co-author Dr. Humberto Scoccia, of the University of Illinois at Chicago. Still, he urged that women who use fertility drugs be [...]

  • Most Women Don’t Need Regular Pelvic Exams, New Guidelines State

    The annual pelvic exam has long been a routine part of women’s health care, but new guidelines say there’s no good reason for it.

  • Pair of Pills Shows Promise for Recurrent Ovarian Cancer

    By Dennis ThompsonHealthDay Reporter SATURDAY, May 31, 2014 (HealthDay News) — A combination of two new pills may nearly double the length of survival for patients with recurrent ovarian cancer, according to preliminary clinical trial results. The therapy combines the drugs olaparib and cediranib. It provided nearly 18 months of progression-free survival on average, as opposed [...]

  • Cheaper ‘Gene Panel’ Screening May Reveal Cancer Risks

    MONDAY, April 14, 2014 (HealthDay News) — A new study found that 10 percent of women with a personal or family history of breast or other cancers had at least one gene mutation that would lead their doctors to recommend changes in their routine care, including increased cancer screening. These women did not have BRCA1 or [...]

WEEKLY NEWSLETTER

Free Health for Women Email Newsletter
Stay fit, feel younger, and get special offers and insider health news—from beauty to breast cancer—just for women.
Advertisement
Health Headlines from Our Partners